Cargando…

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy

Detalles Bibliográficos
Autores principales:	Crippa, IA, Gleeson, J, Fontana, V, Vincent, J-L, Creteur, J, Taccone, FS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796918/ http://dx.doi.org/10.1186/2197-425X-3-S1-A841

Ejemplares similares

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology
por: Gleeson, Patrick James, et al.
Publicado: (2023)

Assessment of chloride levels on renal function after cardiac arrest
por: Righy Shinotsuka, C, et al.
Publicado: (2015)

B-lactams serum concentrations in critically ill cirrhotic patients: a matched-control study
por: Lheureux, O, et al.
Publicado: (2015)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Assessment of early lymphopenia after cardiac arrest
por: Villois, P, et al.
Publicado: (2015)

Red cells distribution width after cardiac arrest
por: Fontana, V, et al.
Publicado: (2015)

Acute renal denervation decreases lactate production in the kidney cortex in experimental septic shock
por: Post, EH, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Angiotensin converting enzymes in patients with acute respiratory distress syndrome
por: Annoni, F, et al.
Publicado: (2015)

A high aminoglycoside regimen associated with renal replacement therapy for the treatment of multi-drug resistant pathogens
por: Brasseur, A, et al.
Publicado: (2015)

Renal replacement in critically ill patients: the age factor
por: Occhigrossi, F, et al.
Publicado: (2004)

A retrospective evaluation of acute kidney injury and effects of renal replacement therapy in septic or nonseptic critically ILL patients
por: Başeğmez, İ, et al.
Publicado: (2015)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

0354. Effects of sodium nitroprusside in addition to therapeutic hypothermia after experimental cardiac arrest
por: Donadello, K, et al.
Publicado: (2014)

Hemodynamic and metabolic alterations associated with septic acute kidney injury in experimental sepsis
por: Post, EH, et al.
Publicado: (2015)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Is the AKIN score useful as an indicator of the optimum time for intervention with renal replacement therapy in critically ill patients?
por: Mousdale, S, et al.
Publicado: (2012)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Effects of rapid repetition of a vascular occlusion test on near-infrared spectroscopy-derived variables in healthy subjects and in critically ill patients
por: Cortes, DO, et al.
Publicado: (2013)

Severe hypophosphatemia in the critically ill: are we replacing enough?
por: Millwood Hargrave, J, et al.
Publicado: (2015)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Trans-nasal cooling during CPR: a single-center experience
por: Taccone, FS, et al.
Publicado: (2010)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Comparison of antemortem clinical diagnosis and post-mortem findings in intensive care unit patients
por: Rusu, Stefan, et al.
Publicado: (2021)

Outcome in critically ill medical patients requiring renal replacement therapy for acute renal failure: comparison between patients with and without hematologic malignancies
por: Benoit, D, et al.
Publicado: (2004)

Bacteremia, APACHE II and need for renal replacement therapy are independent predictors of mortality in critically ill transplanted patients with cirrhosis
por: Karvellas, C, et al.
Publicado: (2010)

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
por: Person, Fermin, et al.
Publicado: (2021)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ns94bh6uqo1l7p8vlluhmbhl8l